← Back to Search

Metabolic Rate Testing for Weight Loss in Bariatric Surgery Candidates

N/A
Waitlist Available
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients scheduled for a primary bariatric surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial checks if knowing a person's resting calorie burn can help predict successful weight loss after surgery for weight loss and guide the choice of the best type of surgery.

Who is the study for?
This trial is for adults of any age who are scheduled to have their first bariatric surgery. It aims to include a broad range of participants without an upper age limit, focusing on those interested in understanding how their body's calorie burning at rest might influence weight loss after surgery.
What is being tested?
The study is testing the use of a ReeVue Indirect Calorimeter, which measures resting metabolic rate—the calories burned while the body is at rest—to see if this can predict successful weight loss following bariatric surgery.
What are the potential side effects?
Since the intervention involves only measuring metabolism with a calorimeter, there are no direct side effects from this procedure. It's non-invasive and simply requires patients to breathe into the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for my first weight loss surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weight decreased
Secondary study objectives
Change in resting metabolic rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Resting Metabolic Rate TestingExperimental Treatment1 Intervention
All subjects will have the resting metabolic rate test. The ReeVue Indirect Calorimeter from Korr Medical will be used to obtain the resting metabolic rate.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
203,375 Total Patients Enrolled
3 Trials studying Weight Loss
216 Patients Enrolled for Weight Loss

Media Library

ReeVue Indirect Calorimeter Clinical Trial Eligibility Overview. Trial Name: NCT03221543 — N/A
Weight Loss Research Study Groups: Resting Metabolic Rate Testing
Weight Loss Clinical Trial 2023: ReeVue Indirect Calorimeter Highlights & Side Effects. Trial Name: NCT03221543 — N/A
ReeVue Indirect Calorimeter 2023 Treatment Timeline for Medical Study. Trial Name: NCT03221543 — N/A
~6 spots leftby Nov 2025